Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | 2-Methylpiperazine | HCID 66057 | — |
| Reactant | 7-Bromo-1-cyclopropyl-6-fluoro-5-methyl-4-oxo-1,4-dihydroquinoline-3-carboxylic acid | HCID 10132015 | — |
| Solvent | N-methyl-2-pyrrolidone | HCID 13387 | — |
| Product | Grepafloxacin | HCID 72474 | 50.6% |
Reaction Steps
To a solution of 1-cyclopropyl-6-fluoro-7-bromo-5-methyl-1,4-dihydro-4-oxoquinoline-3-carboxylic acid (0.58 g) in N-methyl-2-pyrrolidone (5 ml) is added 3-methylpiperazine (0.65 g), and the mixture is heated at 90° C. for 20 minutes. After the solvent is distilled off under reduced pressure, ethanol is added to the residue, and the crystals are separated by filtration and are recrystallized from ethyl acetate-ethanol to give 1-cyclopropyl-6-fluoro-7-(3-methyl-1-piperazinyl)-5-methyl-1,4-dihydro-4-oxoquinoline-3-carboxylic acid (310 mg), as white powdery crystals, m.p. 206°-208° C.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US04971970 |
|---|
| Source dataset | uspto-grants-1990_11 |
|---|
| ORD ID | ord-d60d70b378ba496e83784ec28ad6dcc9 |
|---|
| Source note | uspto-grants-1990_11 |
|---|